Related Experiment Video
Updated: Nov 3, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pneumococcal Vaccination in Immunocompromised Hosts: An Update.
Claire Froneman1, Peter Kelleher1,2, Ricardo J José1,3
1Department of Respiratory Medicine, Royal Brompton Hospital, London SW3 6NP, UK.
Pneumococcal vaccination is crucial for preventing serious infections caused by Streptococcus pneumoniae, especially in vulnerable populations. This discussion highlights the importance of vaccination strategies for immunocompromised individuals to reduce disease burden.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Streptococcus pneumoniae causes significant global morbidity and mortality.
- Infections disproportionately affect the very young, elderly, and immunocompromised.
- Preventing pneumococcal disease is a key public health objective.
Purpose of the Study:
- To review the role of pneumococcal vaccination in immunocompromised hosts.
- To emphasize the importance of vaccination in at-risk populations.
- To provide guidance on pneumococcal prevention strategies.
Main Methods:
- Literature review of pneumococcal vaccination.
- Analysis of disease burden in specific patient groups.
- Discussion of current vaccination recommendations.
Main Results:
- Pneumococcal vaccination is effective in reducing disease incidence.
- Immunocompromised individuals are a priority group for vaccination.
- Vaccination strategies need to be tailored to specific host factors.
Conclusions:
- Pneumococcal vaccination is essential for preventing invasive pneumococcal disease.
- Targeted vaccination programs are vital for immunocompromised populations.
- Continued research and implementation of vaccination are necessary.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...